Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
Abstract A prothrombotic state is a typical feature of type 2 diabetes mellitus (T2DM). Apart from increased platelet reactivity, endothelial dysfunction, hyperfibrinogenemia, and hypofibrinolysis are observed in T2DM. A variety of poorly elucidated mechanisms behind impaired fibrinolysis in this di...
Main Authors: | Agata Hanna Bryk-Wiązania, Anetta Undas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-021-01372-w |
Similar Items
-
Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
by: Agata H. Bryk, et al.
Published: (2019-04-01) -
Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study
by: Agata Hanna Bryk, et al.
Published: (2021-02-01) -
Development and application of global assays of hyper‐ and hypofibrinolysis
by: Anton Ilich, et al.
Published: (2020-01-01) -
Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease
by: Radosław Wieczór, et al.
Published: (2019-07-01) -
Gender specifics of the association between blood fibrinolytic activity and cardiovascular disease or diabetes mellitus in a cohort of Muscovites aged 55 years or older
by: L. A. Ratnikova, et al.
Published: (2012-08-01)